DiabetOmics, Inc. is a global medical diagnostics company pioneering innovative, non-invasive point-of-care tests for the detection and monitoring of diabetes.
Their mission is to advance the health and wellbeing of people with, or at risk for, diabetes through simple, cost-effective, and easily accessible care.
They strive to develop and provide point-of-care testing capabilities that are especially useful in alleviating the substantial economic and public health burden of diabetes in underserved, low-resource environments, particularly for at-risk populations in low/middle-income countries.
